MedTrace Logo

Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health

NCT07458828 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-03-09

No results posted yet for this study

Summary

This study is designed to evaluate the efficacy and safety of Hydrolyzed Keratin Peptide Powder in promoting hair health in adult with mild to moderate hair damage, compared to a placebo control.

Conditions

  • Hair Damage
  • Hair Health
  • Hair Strength

Interventions

DIETARY_SUPPLEMENT

DAP-HAI-403

Each subject takes two capsules per day for 24 weeks. Each capsule contains DAP-HAI-403 250mg.

DIETARY_SUPPLEMENT

Placebo

Each subject takes two capsules per day for 24 weeks.

Sponsors & Collaborators

  • Global Medical Research Center Co., Ltd.

    collaborator INDUSTRY

  • Dong-A Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-23
Primary Completion
2025-01-21
Completion
2025-08-12

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07458828 on ClinicalTrials.gov